GLA and Fabry disease: In Gla-deficient (Fabry) mice, a single injection of AAV8-FLT190 significantly increased α-Gal A activity – both in plasma and tissues affected in Fabry disease – and consequently decreased Gb3 accumulation in multiple tissues, compared with untreated controls.